These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3040612)

  • 1. Opioid neuronal denervation in Gilles de la Tourette syndrome.
    Sandyk R
    Int J Neurosci; 1987 Jul; 35(1-2):95-8. PubMed ID: 3040612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid modulation of gonadotrophin release in Tourette's syndrome.
    Sandyk R; Bamford CR
    Int J Neurosci; 1988 Apr; 39(3-4):233-4. PubMed ID: 3137181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deranged modulatory midbrain opioid and gonadotrophin functions: relevance to Tourette's syndrome.
    Sandyk R; Awerbuch G; Kwo-On-Yuen PF; Bamford CR
    Med Hypotheses; 1991 Sep; 36(1):95-7. PubMed ID: 1766421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disorders in Tourette's syndrome.
    Sandyk R; Bamford CR; Iacono RP
    Int J Neurosci; 1987 Nov; 37(1-2):59-65. PubMed ID: 3479403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opioid system in Gilles de la Tourette's syndrome.
    Sandyk R
    Neurology; 1985 Mar; 35(3):449-50. PubMed ID: 3856116
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated CSF dynorphin A [1-8] in Tourette's syndrome.
    Leckman JF; Riddle MA; Berrettini WH; Anderson GM; Hardin M; Chappell P; Bissette G; Nemeroff CB; Goodman WK; Cohen DJ
    Life Sci; 1988; 43(24):2015-23. PubMed ID: 2463450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.
    Kanaan AS; Gerasch S; García-García I; Lampe L; Pampel A; Anwander A; Near J; Möller HE; Müller-Vahl K
    Brain; 2017 Jan; 140(1):218-234. PubMed ID: 28007998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of hypothalamic dopamine and opioid activity and the pathophysiology of self-mutilatory behavior in Tourette's syndrome.
    Sandyk R; Bamford CR
    J Clin Psychopharmacol; 1987 Oct; 7(5):367. PubMed ID: 3479458
    [No Abstract]   [Full Text] [Related]  

  • 10. Costs of control: decreased motor cortex engagement during a Go/NoGo task in Tourette's syndrome.
    Thomalla G; Jonas M; Bäumer T; Siebner HR; Biermann-Ruben K; Ganos C; Orth M; Hummel FC; Gerloff C; Müller-Vahl K; Schnitzler A; Münchau A
    Brain; 2014 Jan; 137(Pt 1):122-36. PubMed ID: 24176975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.
    Worbe Y; Marrakchi-Kacem L; Lecomte S; Valabregue R; Poupon F; Guevara P; Tucholka A; Mangin JF; Vidailhet M; Lehericy S; Hartmann A; Poupon C
    Brain; 2015 Feb; 138(Pt 2):472-82. PubMed ID: 25392196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tics and Gilles de la Tourette syndrome].
    de Mattos JP; de Rosso AL
    Arq Neuropsiquiatr; 1995 Mar; 53(1):141-6. PubMed ID: 7575199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic supersensitivity factors in Tourette's syndrome: a hypothesis.
    Sandyk R
    Int J Neurosci; 1989 Jan; 44(1-2):169-74. PubMed ID: 2485823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiology of Tourette's syndrome: pathophysiological considerations.
    Segawa M
    Brain Dev; 2003 Dec; 25 Suppl 1():S62-9. PubMed ID: 14980375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
    Nordstrom EJ; Burton FH
    Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endogenous opioid system in Gilles de la Tourette syndrome.
    Gillman MA; Sandyk R
    Med Hypotheses; 1986 Apr; 19(4):371-8. PubMed ID: 2872580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation of Gilles de la Tourette's syndrome associated with thermal stress: a family study.
    Lombroso PJ; Mack G; Scahill L; King RA; Leckman JF
    Neurology; 1991 Dec; 41(12):1984-7. PubMed ID: 1745360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of striatal desensitization in cortical-limbic hyperglutamatergic TS- & OCD-like transgenic mice.
    O'Brien KB; Sharrief AZ; Nordstrom EJ; Travanty AJ; Huynh M; Romero MP; Bittner KC; Bowser MT; Burton FH
    J Chem Neuroanat; 2018 Apr; 89():11-20. PubMed ID: 29481900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gilles de La Tourette's syndrome and some forms of obsessive-compulsive disorder may share a common genetic diathesis.
    Leckman JF; Chittenden EH
    Encephale; 1990; 16 Spec No():321-3. PubMed ID: 2209489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tourette's syndrome: a disorder of cingulate and orbitofrontal function?
    Weeks RA; Turjanski N; Brooks DJ
    QJM; 1996 Jun; 89(6):401-8. PubMed ID: 8758042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.